Clinical Trial Update: Ambroxol in Disease Modification in Parkinson Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ambroxol for disease modification in Parkinson disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Ambroxol (Ambroxol)

Snippet

Sponsor: University College, London | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED